Cite
HARVARD Citation
deFonseka, A. et al. (2016). Antitumor Necrosis Factor-α Therapy Is Associated With Reduced Risk of Thromboembolic Events in Hospitalized Patients With Inflammatory Bowel Disease. Journal of clinical gastroenterology. 50 (7), p. . [Online].